Antenatal dexamethasone before asphyxia promotes cystic neural injury in preterm fetal sheep by inducing hyperglycemia

Christopher A. Lear, Joanne O. Davidson, Georgia R. Mackay, Paul P. Drury, Robert Galinsky, Josine S. Quaedackers, Alistair J. Gunn, Laura Bennet

Research output: Contribution to journalArticleResearchpeer-review

Abstract

Antenatal glucocorticoid therapy significantly improves the short-term systemic outcomes of prematurely born infants, but there is limited information available on their impact on neurodevelopmental outcomes in at-risk preterm babies exposed to perinatal asphyxia. Preterm fetal sheep (0.7 of gestation) were exposed to a maternal injection of 12 mg dexamethasone or saline followed 4 h later by asphyxia induced by 25 min of complete umbilical cord occlusion. In a subsequent study, fetuses received titrated glucose infusions followed 4 h later by asphyxia to examine the hypothesis that hyperglycemia mediated the effects of dexamethasone. Post-mortems were performed 7 days after asphyxia for cerebral histology. Maternal dexamethasone before asphyxia was associated with severe, cystic brain injury compared to diffuse injury after saline injection, with increased numbers of seizures, worse recovery of brain activity, and increased arterial glucose levels before, during, and after asphyxia. Glucose infusions before asphyxia replicated these adverse outcomes, with a strong correlation between greater increases in glucose before asphyxia and greater neural injury. These findings strongly suggest that dexamethasone exposure and hyperglycemia can transform diffuse injury into cystic brain injury after asphyxia in preterm fetal sheep.

Original languageEnglish
Pages (from-to)706-718
Number of pages13
JournalJournal of Cerebral Blood Flow and Metabolism
Volume38
Issue number4
DOIs
Publication statusPublished - 1 Apr 2018
Externally publishedYes

Keywords

  • asphyxia
  • Glucocorticoids
  • hyperglycemia
  • periventricular leukomalacia
  • premature birth

Cite this

Lear, Christopher A. ; Davidson, Joanne O. ; Mackay, Georgia R. ; Drury, Paul P. ; Galinsky, Robert ; Quaedackers, Josine S. ; Gunn, Alistair J. ; Bennet, Laura. / Antenatal dexamethasone before asphyxia promotes cystic neural injury in preterm fetal sheep by inducing hyperglycemia. In: Journal of Cerebral Blood Flow and Metabolism. 2018 ; Vol. 38, No. 4. pp. 706-718.
@article{6a0b094422fa4454be96fd175cadca98,
title = "Antenatal dexamethasone before asphyxia promotes cystic neural injury in preterm fetal sheep by inducing hyperglycemia",
abstract = "Antenatal glucocorticoid therapy significantly improves the short-term systemic outcomes of prematurely born infants, but there is limited information available on their impact on neurodevelopmental outcomes in at-risk preterm babies exposed to perinatal asphyxia. Preterm fetal sheep (0.7 of gestation) were exposed to a maternal injection of 12 mg dexamethasone or saline followed 4 h later by asphyxia induced by 25 min of complete umbilical cord occlusion. In a subsequent study, fetuses received titrated glucose infusions followed 4 h later by asphyxia to examine the hypothesis that hyperglycemia mediated the effects of dexamethasone. Post-mortems were performed 7 days after asphyxia for cerebral histology. Maternal dexamethasone before asphyxia was associated with severe, cystic brain injury compared to diffuse injury after saline injection, with increased numbers of seizures, worse recovery of brain activity, and increased arterial glucose levels before, during, and after asphyxia. Glucose infusions before asphyxia replicated these adverse outcomes, with a strong correlation between greater increases in glucose before asphyxia and greater neural injury. These findings strongly suggest that dexamethasone exposure and hyperglycemia can transform diffuse injury into cystic brain injury after asphyxia in preterm fetal sheep.",
keywords = "asphyxia, Glucocorticoids, hyperglycemia, periventricular leukomalacia, premature birth",
author = "Lear, {Christopher A.} and Davidson, {Joanne O.} and Mackay, {Georgia R.} and Drury, {Paul P.} and Robert Galinsky and Quaedackers, {Josine S.} and Gunn, {Alistair J.} and Laura Bennet",
year = "2018",
month = "4",
day = "1",
doi = "10.1177/0271678X17703124",
language = "English",
volume = "38",
pages = "706--718",
journal = "Journal of Cerebral Blood Flow and Metabolism",
issn = "0271-678X",
publisher = "Nature Publishing Group",
number = "4",

}

Antenatal dexamethasone before asphyxia promotes cystic neural injury in preterm fetal sheep by inducing hyperglycemia. / Lear, Christopher A.; Davidson, Joanne O.; Mackay, Georgia R.; Drury, Paul P.; Galinsky, Robert; Quaedackers, Josine S.; Gunn, Alistair J.; Bennet, Laura.

In: Journal of Cerebral Blood Flow and Metabolism, Vol. 38, No. 4, 01.04.2018, p. 706-718.

Research output: Contribution to journalArticleResearchpeer-review

TY - JOUR

T1 - Antenatal dexamethasone before asphyxia promotes cystic neural injury in preterm fetal sheep by inducing hyperglycemia

AU - Lear, Christopher A.

AU - Davidson, Joanne O.

AU - Mackay, Georgia R.

AU - Drury, Paul P.

AU - Galinsky, Robert

AU - Quaedackers, Josine S.

AU - Gunn, Alistair J.

AU - Bennet, Laura

PY - 2018/4/1

Y1 - 2018/4/1

N2 - Antenatal glucocorticoid therapy significantly improves the short-term systemic outcomes of prematurely born infants, but there is limited information available on their impact on neurodevelopmental outcomes in at-risk preterm babies exposed to perinatal asphyxia. Preterm fetal sheep (0.7 of gestation) were exposed to a maternal injection of 12 mg dexamethasone or saline followed 4 h later by asphyxia induced by 25 min of complete umbilical cord occlusion. In a subsequent study, fetuses received titrated glucose infusions followed 4 h later by asphyxia to examine the hypothesis that hyperglycemia mediated the effects of dexamethasone. Post-mortems were performed 7 days after asphyxia for cerebral histology. Maternal dexamethasone before asphyxia was associated with severe, cystic brain injury compared to diffuse injury after saline injection, with increased numbers of seizures, worse recovery of brain activity, and increased arterial glucose levels before, during, and after asphyxia. Glucose infusions before asphyxia replicated these adverse outcomes, with a strong correlation between greater increases in glucose before asphyxia and greater neural injury. These findings strongly suggest that dexamethasone exposure and hyperglycemia can transform diffuse injury into cystic brain injury after asphyxia in preterm fetal sheep.

AB - Antenatal glucocorticoid therapy significantly improves the short-term systemic outcomes of prematurely born infants, but there is limited information available on their impact on neurodevelopmental outcomes in at-risk preterm babies exposed to perinatal asphyxia. Preterm fetal sheep (0.7 of gestation) were exposed to a maternal injection of 12 mg dexamethasone or saline followed 4 h later by asphyxia induced by 25 min of complete umbilical cord occlusion. In a subsequent study, fetuses received titrated glucose infusions followed 4 h later by asphyxia to examine the hypothesis that hyperglycemia mediated the effects of dexamethasone. Post-mortems were performed 7 days after asphyxia for cerebral histology. Maternal dexamethasone before asphyxia was associated with severe, cystic brain injury compared to diffuse injury after saline injection, with increased numbers of seizures, worse recovery of brain activity, and increased arterial glucose levels before, during, and after asphyxia. Glucose infusions before asphyxia replicated these adverse outcomes, with a strong correlation between greater increases in glucose before asphyxia and greater neural injury. These findings strongly suggest that dexamethasone exposure and hyperglycemia can transform diffuse injury into cystic brain injury after asphyxia in preterm fetal sheep.

KW - asphyxia

KW - Glucocorticoids

KW - hyperglycemia

KW - periventricular leukomalacia

KW - premature birth

UR - http://www.scopus.com/inward/record.url?scp=85038026413&partnerID=8YFLogxK

U2 - 10.1177/0271678X17703124

DO - 10.1177/0271678X17703124

M3 - Article

VL - 38

SP - 706

EP - 718

JO - Journal of Cerebral Blood Flow and Metabolism

JF - Journal of Cerebral Blood Flow and Metabolism

SN - 0271-678X

IS - 4

ER -